Often hidden, psoriasis is a chronic disease affecting more than 125 million patients worldwide. It has a profound impact on quality of life. On this day of solidarity and awareness, ETAP-Lab would like to show its support for psoriasis patients. At ETAP-Lab, we’re already involved in fighting back against psoriasis—our work on developing and providing a translational preclinical research service is driven by our desire to improve quality of life for patients. ETAP-Lab is proud to support the preclinical development of new therapeutics
ETAP-Lab will be attending BioEurope 25 to 28 October. Our experts Dr. Ahmad Allouche (Head of In Vitro Biology) and Dr. Nicolas Violle (CEO) will be there to introduce you to the laboratory's activities in preclinical Dermatology and Neurology, with Stroke, Alzheimer’s and Parkinson’s diseases. Please feel free to contact us to schedule a video conference. We’re hoping to meet you soon!